by Angela | May 27, 2026 | Science Vol 3, Issue 2
The FDA has approved vepdegestrant (Veppanu) for adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer who have progressed after at least one line of endocrine therapy. Angela Alexander, PhD, Sr Clinical...
by Trish Vickery | May 27, 2026 | Events Vol 3, Issue 2, Science Vol 3, Issue 2
Blog by Trish Vickery On April 11, the Dana Farber IBC team held their annual patient forum; the virtual format allowed patients near and far to join. The day included informative medical presentations, followed by an expert roundtable, with a new feature – breakout...
